10243

539268

SYNGENE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SYNGENE INTERNATIONAL LTD Share Price Today

SYNGENE INTERNATIONAL LTD is currently trading at ₹442.95, up by ₹6.95 from the previous close. The stock touched an intraday high of ₹444.75 and a low of ₹435.15 during the latest trading session. Over the past one year, SYNGENE INTERNATIONAL LTD has delivered a loss of 29.73%, while the stock has declined 6.49% in the last one month.

SYNGENE INTERNATIONAL LTD performance

Today’s low Today’s high
₹ 435.15 ₹ 444.75
₹ 437.50
52 week low 52 week high
₹ 380.00 ₹ 728.60
₹ 437.50
Open Price ₹ 439.25
Prev. Close ₹ 436.00
Volume (Shares) 700557.00
Total traded value ₹ 3064.93
Upper Circuit ₹ 523.20
Lower Circuit ₹ 348.80
info

Investment Returns

Over 1 Month -6.49% Over 3 Months 8.06% Over 6 Months -32.62% Over 1 Year -29.73%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SYNGENE INTERNATIONAL LTD fundamentals


  • Market cap (Cr) 17,666.60
  • P/E Ratio (TTM) 58.74
  • Beta 0.86
  • Book Value / share 116.54
  • Return on equity 10.60%
  • EPS (TTM) 8.95
  • Dividend yield 0.28%
  • Net profit/quarter (Cr) 148.20
info icon alternate text
  • Market cap (Cr) 17,666.60
  • P/E Ratio (TTM) 58.74
  • Beta 0.83
  • Book Value / share 116.54
  • Return on equity 10.60%
  • EPS (TTM) 8.95
  • Dividend yield 0.28%
  • Net profit/quarter (Cr) 148.20
info icon alternate text

SYNGENE INTERNATIONAL LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 960.00
Operating Expense 777.50
Net Profit 148.20
Net Profit Margin (%) 15.43
Earnings Per Share (EPS) 3.68
EBITDA 298.50
Effective Tax Rate (%) 24.65
Particulars DEC 2025 (Values in Cr)
Revenue 834.40
Operating Expense 753.00
Net Profit 16.50
Net Profit Margin (%) 1.97
Earnings Per Share (EPS) 0.41
EBITDA 133.40
Effective Tax Rate (%) 45.18
Particulars SEP 2025 (Values in Cr)
Revenue 830.10
Operating Expense 760.10
Net Profit 66.20
Net Profit Margin (%) 7.97
Earnings Per Share (EPS) 1.65
EBITDA 191.70
Effective Tax Rate (%) 21.37
Particulars JUN 2025 (Values in Cr)
Revenue 799.30
Operating Expense 731.69
Net Profit 74.00
Net Profit Margin (%) 9.25
Earnings Per Share (EPS) 1.84
EBITDA 184.70
Effective Tax Rate (%) 12.11
Particulars MAR 2025 (Values in Cr)
Revenue 948.40
Operating Expense 738.10
Net Profit 174.40
Net Profit Margin (%) 18.38
Earnings Per Share (EPS) 4.34
EBITDA 328.40
Effective Tax Rate (%) 23.74
Particulars MAR 2026 (Values in Cr)
Revenue 3423.80
Operating Expense 3022.30
Net Profit 304.90
Net Profit Margin (%) 8.90
Earnings Per Share (EPS) 7.58
EBITDA 808.30
Effective Tax Rate (%) 22.84
Particulars MAR 2025 (Values in Cr)
Revenue 3373.30
Operating Expense 2854.20
Net Profit 468.00
Net Profit Margin (%) 13.87
Earnings Per Share (EPS) 11.64
EBITDA 1020.10
Effective Tax Rate (%) 24.71
Particulars MAR 2024 (Values in Cr)
Revenue 3203.10
Operating Expense 2722.70
Net Profit 466.50
Net Profit Margin (%) 14.56
Earnings Per Share (EPS) 11.62
EBITDA 955.69
Effective Tax Rate (%) 16.29
Particulars MAR 2023 (Values in Cr)
Revenue 3193.50
Operating Expense 2663.50
Net Profit 473.00
Net Profit Margin (%) 14.81
Earnings Per Share (EPS) 11.81
EBITDA 1005.20
Effective Tax Rate (%) 21.28
Particulars MAR 2022 (Values in Cr)
Revenue 2601.40
Operating Expense 2141.79
Net Profit 393.80
Net Profit Margin (%) 15.13
Earnings Per Share (EPS) 9.89
EBITDA 815.50
Effective Tax Rate (%) 18.24
Particulars MAR 2025 (Values in Cr)
Book Value / Share 117.44
ROE % 11.05
ROCE % 13.37
Total Debt to Total Equity 0.13
EBITDA Margin 31.45
Particulars MAR 2024 (Values in Cr)
Book Value / Share 105.91
ROE % 12.95
ROCE % 13.56
Total Debt to Total Equity 0.17
EBITDA Margin 31.36
Particulars MAR 2023 (Values in Cr)
Book Value / Share 90.13
ROE % 13.43
ROCE % 13.64
Total Debt to Total Equity 0.27
EBITDA Margin 31.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 82.28
ROE % 12.94
ROCE % 11.77
Total Debt to Total Equity 0.31
EBITDA Margin 31.42
Particulars MAR 2021 (Values in Cr)
Book Value / Share 70.54
ROE % 16.21
ROCE % 13.54
Total Debt to Total Equity 0.33
EBITDA Margin 35.32
Particulars MAR 2025 (Values in Cr)
Book Value / Share 115.25
ROE % 10.60
ROCE % 13.04
Total Debt to Total Equity 0.07
EBITDA Margin 30.24
Particulars MAR 2024 (Values in Cr)
Book Value / Share 104.27
ROE % 11.95
ROCE % 12.51
Total Debt to Total Equity 0.12
EBITDA Margin 29.84
Particulars MAR 2023 (Values in Cr)
Book Value / Share 90.16
ROE % 13.69
ROCE % 14.07
Total Debt to Total Equity 0.24
EBITDA Margin 31.48
Particulars MAR 2022 (Values in Cr)
Book Value / Share 82.14
ROE % 12.89
ROCE % 11.72
Total Debt to Total Equity 0.31
EBITDA Margin 31.35
Particulars MAR 2021 (Values in Cr)
Book Value / Share 70.46
ROE % 16.17
ROCE % 13.50
Total Debt to Total Equity 0.33
EBITDA Margin 35.31
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 787.00
Total Assets 6795.90
Total Liabilities 6795.90
Total Equity 4726.80
Share Outstanding 40
Price to Book Ratio 6.30
Return on Assets (%) 7.30
Return on Capital (%) 10.24
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 563.50
Total Assets 6151.60
Total Liabilities 6151.60
Total Equity 4257.70
Share Outstanding 40
Price to Book Ratio 6.73
Return on Assets (%) 8.29
Return on Capital (%) 11.59
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 531.70
Total Assets 5831.00
Total Liabilities 5831.00
Total Equity 3618.00
Share Outstanding 40
Price to Book Ratio 6.59
Return on Assets (%) 7.96
Return on Capital (%) 11.07
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 517.90
Total Assets 5563.80
Total Liabilities 5563.80
Total Equity 3297.60
Share Outstanding 40
Price to Book Ratio 7.27
Return on Assets (%) 7.11
Return on Capital (%) 9.68
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 642.60
Total Assets 4883.20
Total Liabilities 4883.20
Total Equity 2821.40
Share Outstanding 40
Price to Book Ratio 7.71
Return on Assets (%) 8.29
Return on Capital (%) 11.27
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 652.50
Total Assets 6406.90
Total Liabilities 6406.90
Total Equity 4638.90
Share Outstanding 40
Price to Book Ratio 6.30
Return on Assets (%) 7.30
Return on Capital (%) 9.87
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 528.20
Total Assets 5833.90
Total Liabilities 5833.90
Total Equity 4191.50
Share Outstanding 40
Price to Book Ratio 6.73
Return on Assets (%) 7.99
Return on Capital (%) 10.77
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 509.30
Total Assets 5848.00
Total Liabilities 5848.00
Total Equity 3618.90
Share Outstanding 40
Price to Book Ratio 6.59
Return on Assets (%) 8.08
Return on Capital (%) 11.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 515.10
Total Assets 5560.80
Total Liabilities 5560.80
Total Equity 3292.00
Share Outstanding 40
Price to Book Ratio 7.27
Return on Assets (%) 7.08
Return on Capital (%) 9.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 638.20
Total Assets 4877.50
Total Liabilities 4877.50
Total Equity 2818.30
Share Outstanding 40
Price to Book Ratio 7.71
Return on Assets (%) 8.27
Return on Capital (%) 11.24
Particulars MAR 2025 (Values in Cr)
Net Income 496.20
Cash from Operations 1282.90
Cash from Investing -744.70
Cash from Financing -141.80
Net change in Cash 281.10
Free Cash Flow 2043.20
Particulars MAR 2024 (Values in Cr)
Net Income 510.00
Cash from Operations 1167.20
Cash from Investing -495.60
Cash from Financing -551.40
Net change in Cash -4.90
Free Cash Flow 1659.20
Particulars MAR 2023 (Values in Cr)
Net Income 464.40
Cash from Operations 960.30
Cash from Investing -656.40
Cash from Financing -342.50
Net change in Cash -175.40
Free Cash Flow 1466.90
Particulars MAR 2022 (Values in Cr)
Net Income 395.80
Cash from Operations 686.40
Cash from Investing -611.50
Cash from Financing -31.30
Net change in Cash -62.20
Free Cash Flow 1161.70
Particulars MAR 2021 (Values in Cr)
Net Income 404.90
Cash from Operations 784.80
Cash from Investing -628.10
Cash from Financing 58.00
Net change in Cash 131.10
Free Cash Flow 1225.60
Particulars MAR 2025 (Values in Cr)
Net Income 468.00
Cash from Operations 1215.30
Cash from Investing -810.40
Cash from Financing -136.50
Net change in Cash 166.90
Free Cash Flow 1584.60
Particulars MAR 2024 (Values in Cr)
Net Income 466.50
Cash from Operations 1011.80
Cash from Investing -383.50
Cash from Financing -536.30
Net change in Cash -6.40
Free Cash Flow 1362.90
Particulars MAR 2023 (Values in Cr)
Net Income 473.00
Cash from Operations 972.10
Cash from Investing -688.20
Cash from Financing -340.20
Net change in Cash -190.00
Free Cash Flow 1493.50
Particulars MAR 2022 (Values in Cr)
Net Income 393.80
Cash from Operations 686.40
Cash from Investing -611.50
Cash from Financing -31.30
Net change in Cash -60.60
Free Cash Flow 1161.70
Particulars MAR 2021 (Values in Cr)
Net Income 403.70
Cash from Operations 780.80
Cash from Investing -628.10
Cash from Financing 58.00
Net change in Cash 127.90
Free Cash Flow 1221.60
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 62.45 12.89 122170.95 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.22 23.63 2.85 97.87 40.75 76.00
SHREE PACETRONIX LTD. 134.30 16.03 2.82 50.36 66.10 283.15
TRANSGENE BIOTEK LTD. 3.16 0.00 2.85 23.94 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 81.38 12.26 122170.95 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.25 0.00 -9.55 29.32 30.30 57.48
KOVAI MEDICAL CENTER & HO 5834.80 26.11 4.83 6383.27 5010.00 6725.00

SYNGENE INTERNATIONAL LTD shareholding pattern

Holding
6.97%
52.68%
13.9%
26.43%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

SYNGENE INTERNATIONAL LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
437.65 -1.29 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 444.60
  • 26 Days 448.50
  • 10 Days 446.50
  • 50 Days 449.40
  • 12 Days 447.00
  • 100 Days 469.40
  • 20 Days 448.40
  • 200 Days 524.50
441.00 PIVOT
First Support 436.05 First Resistance 445.70 Second Support 431.35 Second Resistance 450.65 Third Support 426.40 Third Resistance 455.35
RSI 45.34 ADX 27.48 MACD -1.26 Williams % R -72.83 Commodity Channel Index (CCI) -80.50
Date 2026-06-19 Week 330694.00 Same Day 478321.00 Month 369212.00
1 Year 0.86 3 Year 0.72
Over 1 Month
-6.49% down
Over 1 Year
-29.73% down
Over 3 Months
8.06% down
Over 3 Years
-15.98% down
Over 6 Months
-32.62% down
Over 5 Years
-5.46% down

SYNGENE INTERNATIONAL LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
25 Jun 2026 1.25 Final 26 Jun 2026 Equity shares
27 Jun 2025 1.25 Final 27 Jun 2025 Equity shares
28 Jun 2024 1.25 Final 28 Jun 2024 Equity shares
30 Jun 2023 0.75 Special 30 Jun 2023 Equity shares
30 Jun 2023 0.5 Final 30 Jun 2023 Equity shares
30 Jun 2022 0.5 Special 01 Jul 2022 Equity shares
30 Jun 2022 0.5 Final 01 Jul 2022 Equity shares
16 Jul 2019 0.5 Final 17 Jul 2019 Equity shares
17 Jul 2018 1.0 Final 18 Jul 2018 Equity shares
20 Jul 2017 1.0 Final 21 Jul 2017 Equity shares
17 Mar 2016 1.0 Interim 19 Mar 2016 Equity shares
Ex-Date Ex-Bonus Ratio
12 Jun 2019 11 Jun 2019 1:1
Dividend date Dividend amount Dividend type Record date Instrument type
25 Jun 2026 1.25 Final 26 Jun 2026 Equity shares
27 Jun 2025 1.25 Final 27 Jun 2025 Equity shares
28 Jun 2024 1.25 Final 28 Jun 2024 Equity shares
30 Jun 2023 0.75 Special 30 Jun 2023 Equity shares
30 Jun 2023 0.5 Final 30 Jun 2023 Equity shares
30 Jun 2022 0.5 Special 01 Jul 2022 Equity shares
30 Jun 2022 0.5 Final 01 Jul 2022 Equity shares
16 Jul 2019 0.5 Final 17 Jul 2019 Equity shares
17 Jul 2018 1.0 Final 18 Jul 2018 Equity shares
20 Jul 2017 1.0 Final 21 Jul 2017 Equity shares
17 Mar 2016 1.0 Interim 19 Mar 2016 Equity shares
Ex-Date Ex-Bonus Ratio
12 Jun 2019 11 Jun 2019 1:1

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Syngene International Ltd?

Answer Field

Syngene International Ltd share price is for NSE ₹ 442.95 & for BSE ₹ 442.00 as on Jun 24 2026 03:30 PM.

What is the Market Cap of Syngene International Ltd Share?

Answer Field

The market cap of Syngene International Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 24 2026 03:30 PM.

What is the 52 Week High and Low of Syngene International Ltd?

Answer Field

The 52 Week High and Low of Syngene International Ltd for NSE is ₹ 728.60 and ₹ 380.00 and for BSE is ₹ 728.40 and ₹ 380.00.

What is 1 year return for Syngene International Ltd?

Answer Field

The 1 year returns on the stock has been -30.28%.

What is the P/E Ratio of Syngene International Ltd Share?

Answer Field

As on Jun 24 2026 03:30 PM the price-to-earnings (PE) ratio for Syngene International Ltd share is 58.74.

What is the PB ratio of Syngene International Ltd Share?

Answer Field

As on Jun 24 2026 03:30 PM, the price-to-book (PB) ratio for Syngene International Ltd share is 116.54.

How to Buy Syngene International Ltd Share?

Answer Field

You can trade in Syngene International Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Syngene International Ltd Share on Bajaj Broking App?

Answer Field

To buy Syngene International Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Syngene International Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|